Costs and Expenses in USD of BioCardia, Inc. from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
BioCardia, Inc. quarterly and annual Costs and Expenses history and change rate from 2015 to Q3 2025.
  • BioCardia, Inc. Costs and Expenses for the quarter ending 30 Sep 2025 was $1,488,000, a 15% decline year-over-year.
  • BioCardia, Inc. Costs and Expenses for the twelve months ending 30 Sep 2025 was $8,586,000, a 9.6% increase year-over-year.
  • BioCardia, Inc. annual Costs and Expenses for 2024 was $8,059,000, a 34% decline from 2023.
  • BioCardia, Inc. annual Costs and Expenses for 2023 was $12,121,000, a 8.5% decline from 2022.
  • BioCardia, Inc. annual Costs and Expenses for 2022 was $13,253,000, a 2.9% decline from 2021.
Source SEC data
View on sec.gov
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)

BioCardia, Inc. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,586,000 $1,488,000 -$268,000 -15% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $8,854,000 $2,051,000 +$399,000 +24% 01 Apr 2025 30 Jun 2025 10-Q/A 29 Oct 2025 2025 Q2
Q1 2025 $8,455,000 $2,726,000 +$396,000 +17% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $8,059,000 $2,321,000 +$224,000 +11% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q3 2024 $7,835,000 $1,756,000 -$1,199,000 -41% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $9,034,000 $1,652,000 -$1,843,000 -53% 01 Apr 2024 30 Jun 2024 10-Q/A 29 Oct 2025 2025 Q2
Q1 2024 $10,877,000 $2,330,000 -$1,244,000 -35% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $12,121,000 $2,097,000 -$1,027,000 -33% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $13,148,000 $2,955,000 -$317,000 -9.7% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $13,465,000 $3,495,000 +$25,000 +0.72% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $13,440,000 $3,574,000 +$187,000 +5.5% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $13,253,000 $3,124,000 -$416,000 -12% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $13,669,000 $3,272,000 -$257,000 -7.3% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $13,926,000 $3,470,000 -$88,000 -2.5% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $14,014,000 $3,387,000 +$369,000 +12% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $13,645,000 $3,540,000 -$4,000 -0.11% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $13,649,000 $3,529,000 -$353,000 -9.1% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $14,002,000 $3,558,000 -$43,000 -1.2% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $14,045,000 $3,018,000 -$1,629,000 -35% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q4 2020 $15,674,000 $3,544,000 -$207,000 -5.5% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $15,881,000 $3,882,000 +$461,000 +13% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $15,420,000 $3,601,000 -$247,000 -6.4% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $15,667,000 $4,647,000 +$744,000 +19% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $14,923,000 $3,751,000 -$12,000 -0.32% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $14,935,000 $3,421,000 -$233,000 -6.4% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $15,168,000 $3,848,000 +$357,000 +10% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $14,811,000 $3,903,000 +$84,000 +2.2% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 $14,727,000 $3,763,000 +$140,000 +3.9% 01 Oct 2018 31 Dec 2018 10-K 09 Apr 2020 2019 FY
Q3 2018 $14,587,000 $3,654,000 +$485,000 +15% 01 Jul 2018 30 Sep 2018 10-Q 19 Nov 2019 2019 Q3
Q2 2018 $14,102,000 $3,491,000 +$411,000 +13% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $13,691,000 $3,819,000 +$807,000 +27% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $12,884,000 $3,623,000 +$14,000 +0.39% 01 Oct 2017 31 Dec 2017 10-K 09 Apr 2020 2019 FY
Q3 2017 $12,870,000 $3,169,000 +$1,370,000 +76% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $11,500,000 $3,080,000 +$1,558,000 +102% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $9,942,000 $3,012,000 +$1,758,000 +140% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $8,184,000 $3,609,000 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2019 2018 FY
Q3 2016 $1,799,000 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 $1,522,000 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $1,254,000 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1

BioCardia, Inc. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $8,059,000 -$4,062,000 -34% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
2023 $12,121,000 -$1,132,000 -8.5% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $13,253,000 -$392,000 -2.9% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $13,645,000 -$2,029,000 -13% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $15,674,000 +$751,000 +5% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $14,923,000 +$196,000 +1.3% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $14,727,000 +$1,843,000 +14% 01 Jan 2018 31 Dec 2018 10-K 09 Apr 2020 2019 FY
2017 $12,884,000 +$4,700,000 +57% 01 Jan 2017 31 Dec 2017 10-K 09 Apr 2020 2019 FY
2016 $8,184,000 +$1,871,000 +30% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2019 2018 FY
2015 $6,313,000 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.